NCT01344356 - Stereotactic Body Radiotherapy for Head and Neck Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions

Squamous Cell Carcinoma of the Head and NeckNasopharyngeal CarcinomaSalivary Gland CancerHead and Neck SarcomaParaganglioma of Head and NeckChordoma of Head and NeckChondrosarcoma of Head and NeckAngiofibroma of Head and Neck

Interventions

RADIATION

stereotactic body radiotherapy

14-16 Gy / 1 fraction OR 18-21 Gy / 3 fractions (6-7 Gy per fraction)OR 25-45 Gy / 5 fractions (5-9 Gy per fraction)

RADIATION

Stereotactic body radiotherapy

8-12 Gy / 1 fraction OR 12-18 Gy / 3 fractions (4-6 Gy per fraction) OR 35-45 Gy / 5 fractions (7-9 Gy per fraction)

Trial Locations (1)

63141

St. John's Mercy Medical Center, St Louis